4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000107
Director acquired 62,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. Director | 2022-07-19 | Option exercise | +62,500 | $0.68 | $42,500 | 151,721 | D |
| Derivatives | |||||||
| Krognes Steve E. Director | 2022-07-19 | Option exercise · Stock Option (right to buy) | −62,500 | 0 | D | ||
Loading xslF345X03/wf-form4_165844658516817.xml…